Showing 61 - 80 results of 237 for search '"pharmacodynamics"', query time: 0.04s Refine Results
  1. 61
  2. 62

    Intra- and Interspecies Conjugal Transfer of Plasmids in Gram-Negative Bacteria by Julia R. Savelieva, Daria A. Kondratieva, Maria V. Golikova

    Published 2025-01-01
    “…<i>P. aeruginosa</i> did not acquire plasmids from <i>K. pneumoniae</i>. In pharmacodynamic experiments, an <i>E. coli</i> transconjugant with MIC of 2 mg/L within the “susceptibility range”, failed to respond to meropenem treatment. …”
    Get full text
    Article
  3. 63

    The theses for MD degree by article Editorial

    Published 2011-03-01
    “…Aleksandrova – Extracorporeal hemocorrection in the complex treatment of liver failure.O.V.Dobrovolsky – Pharmakokinetics and potentials of endoscopic evaluation of esomeprazole pharmacodynamics.O.V. Paklina – Morphogenesis of chronic pancreatitis and pancreatic ductal adenocarcinoma.…”
    Get full text
    Article
  4. 64
  5. 65

    The theses for MD degree by article Editorial

    Published 2011-02-01
    “…Fedorov – Pharmakokinetics and pharmacodynamics of rabeprazole.…”
    Get full text
    Article
  6. 66
  7. 67
  8. 68

    Phase 1 study of novel anti-platelet agent to overcome pharmacogenomic limitations of clopidogrel by Anil Pareek, Nitin Chandurkar, Vivek Raut, Kumar Naidu

    Published 2025-02-01
    “…The pharmacokinetics and pharmacodynamics were assessed on day 1 and day 6 at several time intervals.Results Overall result of pharmacodynamic parameters showed that mean %inhibition of platelet aggregation between AT-10 and clopidogrel in all subjects at 6 hours postdose (loading dose) (AT-10: clopidogrel; 73.30% vs 18.53%) and 6 hours postdose on day 6 (maintenance dose) (AT-10: clopidogrel; 83.41% vs 51.19 %) obtained from the AT-10 group was significantly higher than the clopidogrel group. …”
    Get full text
    Article
  9. 69

    CURRENT APPROACH TO DEVELOPMENT OF BIOSIMILAR PRODUCTS CONTAINING MONOCLONAL ANTIBODIES AS AN ACTIVE SUBSTANCE – NON-CLINICAL AND CLINICAL STUDIES OF THE FIRST RUSSIAN RITUXIMAB BI... by S. M. Alekseev, K. D. Kaplanov, R. A. Ivanov, E. V. Chernyaeva

    Published 2015-04-01
    “…Acellbia is non-inferior to MabThera in terms of efficacy, pharmacokinetics, pharmacodynamics and immunogenicity. Acellbia was well tolerated, with the safety profile comparable with MabThera’s parameters.…”
    Get full text
    Article
  10. 70
  11. 71

    Buprenorphine and its formulations: a comprehensive review by Salomon Poliwoda, Nazir Noor, Jack S. Jenkins, Cain W. Stark, Mattie Steib, Jamal Hasoon, Giustino Varrassi, Ivan Urits, Omar Viswanath, Adam M. Kaye, Alan D Kaye

    Published 2022-08-01
    “…Buprenorphine, a novel long-acting analgesic, was developed with the intention of two purposes: analgesia and opioid use disorder. Regarding its pharmacodynamics, it is a partial agonist at mu receptors, an inverse agonist at kappa receptors, and an antagonist at delta receptors. …”
    Get full text
    Article
  12. 72

    Cardiovascular Side Effects of Atomoxetine and Its Interactions with Inhibitors of the Cytochrome P450 System by Pashtoon Murtaza Kasi, Rawad Mounzer, George H. Gleeson

    Published 2011-01-01
    “…Here, we present a case of a patient who presented with syncope, orthostatic hypotension, and tachycardia and discuss the various clinical implications based on the pharmacokinetics and pharmacodynamics of the drug.…”
    Get full text
    Article
  13. 73

    Delayed-Onset Seizure in a Mild Quetiapine Overdose: Report of a Case and Review of the Literature by Jason A. Chen, Katherine M. Unverferth, Erick H. Cheung

    Published 2018-01-01
    “…The pharmacokinetics and pharmacodynamics of quetiapine may explain this unusual phenomenon.…”
    Get full text
    Article
  14. 74

    Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations by Inder Sehgal

    Published 2023-07-01
    “…This review summarizes pharmacodynamics, comparative dosing, adverse effects, monitoring, and potential pharmacogenetic influence of current pharmacotherapy. …”
    Get full text
    Article
  15. 75
  16. 76

    Sex-related differences in heart failure patients: physiological mechanisms of cardiovascular ageing and evidence-based sex-specific medical therapies by Andra Maria Ciutac, Tiberiu Pana, Dana Dawson, Phyo Kyaw Myint

    Published 2025-01-01
    “…The pharmacokinetics and pharmacodynamics of the common HF medications, classified according to the established sub-types, are summarised with respect to sex-specific documented findings. …”
    Get full text
    Article
  17. 77

    Inefficacy or Paradoxical Effect? Uveitis in Ankylosing Spondylitis Treated with Etanercept by Bernd Raffeiner, Francesca Ometto, Livio Bernardi, Costantino Botsios, Leonardo Punzi

    Published 2014-01-01
    “…The available TNFα blockers show different pharmacokinetics and pharmacodynamics yielding different biological effects. …”
    Get full text
    Article
  18. 78

    Interspecies In Vitro Evaluation of Stereoselective Protein Binding for 3,4-Methylenedioxymethamphetamine by Wan Raihana Wan Aasim, Soo Choon Tan, Siew Hua Gan

    Published 2017-01-01
    “…Since stereoselectivity plays an important role in MDMA’s pharmacokinetics and pharmacodynamics, in this study we investigated its stereoselectivity in protein binding. …”
    Get full text
    Article
  19. 79

    Multifunctional Synthetic Poly(-Glutamic Acid)–Based Cancer Therapeutic and Imaging Agents by Marites P. Melancon, Chun Li

    Published 2011-01-01
    “…Having both an anticancer drug and an imaging reporter in a single polymer chain allows noninvasive real-time visualization of the pharmacokinetics of polymeric drug delivery systems, which can uncover and explain the complicated mechanisms of in vivo drug delivery and their correlation to pharmacodynamics. This review examines the use of the synthetic biocompatible polymer poly( l -glutamic acid) (PG) as an efficient carrier of cancer therapeutics and imaging agents. …”
    Get full text
    Article
  20. 80

    How to improve the quality of euglycemic glucose clamp tests in long-acting insulin studies by Yi Yang, Fu Kuang, XueYing Zhu, Li Li, Yao Huang, Yang Liu, Xian Yu

    Published 2025-02-01
    “…Abstract Background The euglycemic clamp test stands as the best method for assessing the pharmacokinetic and pharmacodynamic properties of long-acting insulin. However, despite its widespread use, there remains a notable absence of an established gold standard for evaluating the test’s quality. …”
    Get full text
    Article